Nanomedical Diagnostics is a San Diego, CA-based biotech company developing and commercializing bioelectronics, specifically graphene biological field effect transistor (BioFET) products. The company combines expertise in biology, nanotechnology, surface chemistry, engineering and manufacturing to create its BioFET products. Its near-term commercial product is AGILE Research, a label-free, quantitative tool for small molecule and protein analysis slated to launch early 2016 for research use only. The company is also pursuing investigational product evaluation and market clearance for AGILE Lyme. Nanomedical intends to use the financing to support the commercial release of AGILE Research and the regulatory and market-clearance activities for AGILE Lyme. The company is led by CEO Ross Bundy.

Total raised

$2M

Funding rounds

1

Latest round

Series A

Latest activity

Oct 2015